The latest price target for Boston Scientific (NYSE:BSX) was reported by Truist Securities on December 18, 2024. The analyst firm set a price target for $110.00 expecting BSX to rise to within 12 months (a possible 23.66% upside). 78 analyst firms have reported ratings in the last year.

The latest analyst rating for Boston Scientific (NYSE:BSX) was provided by Truist Securities, and Boston Scientific maintained their buy rating.

The last upgrade for Boston Scientific Corp happened on February 1, 2024 when Mizuho raised their price target to $80. Mizuho previously had a neutral for Boston Scientific Corp.

The last downgrade for Boston Scientific Corp happened on October 18, 2024 when Needham changed their price target from $86 to $86 for Boston Scientific Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Boston Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Boston Scientific was filed on December 18, 2024 so you should expect the next rating to be made available sometime around December 18, 2025.

While ratings are subjective and will change, the latest Boston Scientific (BSX) rating was a maintained with a price target of $100.00 to $110.00. The current price Boston Scientific (BSX) is trading at is $88.95, which is out of the analyst’s predicted range.